Sorafenib in Treating Patients With Metastatic Breast Cancer

Summary

This phase II trial is studying how well sorafenib works in treating patients with metastatic breast cancer. Sorafenib may stop the growth of tumor cells by blocking the enzymes necessary for their growth and by stopping blood flow to the tumor.

Timeline

Start

2004-09

Primary completion

2006-06

Completion

—

Drugs

Indications